← FDA DRUG APPROVALS

FDA ANDA · ANDA085375

TYLOX

Sponsor: ORTHO MCNEIL PHARM

APPLICATION
ANDA085375
TYPE
ANDA
LATEST ACTION
1984-10-02
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

TYLOXDiscontinued
ACETAMINOPHEN 500MG, OXYCODONE HYDROCHLORIDE 4.5MG, OXYCODONE TEREPHTHALATE 0.38MG · CAPSULE · ORAL

Approval history

1984-10-02Manufacturing (CMC) · Supplement 11AP
1984-05-15Manufacturing (CMC) · Supplement 13AP
1983-01-31Manufacturing (CMC) · Supplement 12AP
1982-05-13Manufacturing (CMC) · Supplement 9AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →